STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 100 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $58,706 | -64.6% | 14,900 | -4.5% | 0.00% | -50.0% |
Q2 2023 | $165,828 | +25.2% | 15,600 | -1.9% | 0.00% | +100.0% |
Q1 2023 | $132,447 | -16.1% | 15,900 | -7.0% | 0.00% | -50.0% |
Q4 2022 | $157,833 | -19.1% | 17,100 | +12.5% | 0.00% | 0.0% |
Q3 2022 | $195,168 | -39.4% | 15,200 | -0.7% | 0.00% | -33.3% |
Q1 2022 | $322,000 | – | 15,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |